Clinical Trial Update: HA35 Moderate Alcoholic Hepatitis (AH) Study [EARLY_Phase 1]

View source ↗

Summary

HA35 is being studied in an early-phase 1 trial for moderate alcoholic hepatitis, and the study is currently recruiting. Sponsor is The Cleveland Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• HA35

Snippet

Sponsor: The Cleveland Clinic | Conditions: Alcoholic Hepatitis | EARLY_Phase 1 | Status: RECRUITING